|
TGFβRI-IN-3
|
|
2763602-67-9
|
|
PD184161
|
|
212631-67-9
|
|
MRT-81
|
|
1263132-08-6
|
|
M2N12
|
|
2376577-06-7
|
|
Abelacimab
|
阿贝西单抗
|
2098724-83-3
|
|
Gosuranemab
|
|
1788032-39-2
|
|
M435-1279
|
|
1359431-16-5
|
|
DATP-N3
|
|
1048021-78-8
|
|
AA38-3
|
|
65815-76-1
|
|
Belantamab
|
贝兰妥单抗
|
2061894-48-0
|
|
Rolinsatamab
|
洛林妥单抗
|
2095467-30-2
|
|
Toripalimab
|
特瑞普利单抗
|
1924598-82-2
|
|
2-Deoxy-2-fluoro-D-galactose
|
2-氟-alfa-d-2-脱氧-葡萄糖
|
7226-39-3
|
|
6-Chloropurine -9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside
|
6-氯-9-(3,5-二-O-苯甲酰基-2-脱氧-2-氟-BETA-D-阿拉伯呋喃糖基)-9H-嘌呤
|
135473-15-3
|
|
N-Desmethyltamoxifen
|
去甲基他莫昔芬
|
31750-48-8
|
|
DUBs-IN-2
|
|
924296-19-5
|
|
SP141
|
|
1253491-42-7
|
|
Esomeprazole Impurity 3
|
埃索美拉唑杂质3
|
1346599-85-6
|
|
KGP94
|
|
1131456-28-4
|
|
MP07-66
|
|
1938056-90-6
|
|
Omburtamab
|
奥博妥单抗
|
1895083-75-6
|
|
Spesolimab
|
司柏索利单抗
|
2097104-58-8
|
|
SGK1-IN-4
|
|
1628048-93-0
|
|
AM-9747
|
|
2691869-82-4
|
|
WQ 1
|
|
1204401-49-9
|
|
Paprotrain
|
|
57046-73-8
|
|
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol
|
6,7-二氢-5H-吡咯并[1,2-A]咪唑-6-醇
|
1378606-06-4
|
|
PI-273
|
|
925069-34-7
|
|
Budigalimab
|
布格利单抗
|
2098225-93-3
|
|
Marstacimab
|
马塔西单抗
|
1985638-39-8
|
|
(3S)-3-(2,2,2-Trifluoroethyl)pyrrolidine
|
(3S)-3-(2,2,2-三氟乙基)吡咯烷
|
1430091-57-8
|
|
KA2507
|
|
1636894-46-6
|
|
SBP3264
|
|
|
|
Calmidazolium chloride
|
钙调蛋白抑制剂
|
57265-65-3
|
|
SU16f
|
|
251356-45-3
|
|
L002
|
|
321695-57-2
|
|
R-Avanafil
|
R-阿伐那非
|
1638497-26-3
|
|
NDMC101
|
|
1308631-40-4
|
|
JJKK048
|
|
1515855-97-6
|
|
TC-FPR 43
|
|
903895-98-7
|
|
AZD-5099
|
|
907543-25-3
|
|
ML328
|
|
634175-34-1
|
|
M-525
|
|
2173582-08-4
|
|
Olinvacimab
|
奥伐西单抗
|
2095504-49-5
|
|
Dostarlimab
|
多塔利单抗
|
2022215-59-2
|
|
Zampilimab
|
|
2098280-42-1
|
|
Cobolimab
|
考伯利单抗
|
2022215-65-0
|
|
SB-747651A
|
|
607372-46-3
|
|
CDK4/6-IN-6
|
|
2380321-51-5
|
|
BMS-986122
|
|
313669-88-4
|
|
WAY-204688
|
|
796854-35-8
|
|
PA 452
|
|
457657-34-0
|
|
SPP-86
|
|
1357349-91-7
|
|
2-Oxa-6,9-diazaspiro[4.5]decane-6-carboxylic acid, 1,1-dimethylethyl ester
|
2-氧杂-6,9-二氮杂螺[4.5]癸烷-6-羧酸叔丁酯
|
1784402-13-6
|
|
Prolgolimab
|
帕洛利单抗
|
2093956-19-3
|
|
Tabituximab
|
坦比妥昔单抗
|
1644134-10-0
|
|
8-Bromo-3-chloro-5-isopropylisoquinoline
|
8-溴-3-氯-5-异丙基异喹啉
|
2660255-85-4
|
|
MAO-B-IN-2
|
|
1253978-24-3
|
|
Tafluprost Impurity 16Z
|
他氟前列素16Z型杂质
|
|
|
CAY10574
|
|
140651-18-9
|
|
Diprotin A
|
抑二肽素A
|
90614-48-5
|
|
RO-9187
|
|
876708-03-1
|
|
MRT10
|
|
330829-30-6
|
|
SM-7368
|
|
380623-76-7
|
|
Sappanone A
|
苏木酮A
|
102067-84-5
|
|
SB-747651A dihydrochloride
|
|
1781882-72-1
|
|
GSK1379725A
|
|
1802251-00-8
|
|
PP7
|
|
433238-84-7
|
|
Alkyne tyramide
|
|
1694495-59-4
|
|
Cemiplimab
|
西米普利单抗
|
1801342-60-8
|
|
Nirsevimab
|
尼塞韦单抗
|
1989556-22-0
|
|
Mezagitamab
|
迈泽妥单抗
|
2227490-52-8
|
|
AP1189 acetate
|
|
959850-74-9
|
|
NLG802
|
|
2071683-99-1
|
|
2,2-Dimethylhexanal
|
|
996-12-3
|
|
SC-1
|
|
1313019-65-6
|
|
Vazegepant
|
|
1337918-83-8
|
|
STAT5-IN-2
|
|
2111834-61-6
|
|
Murlentamab
|
莫伦妥单抗
|
2058047-65-5
|
|
Frovocimab
|
弗洛西单抗
|
1643672-70-1
|
|
Gancotamab
|
甘妥单抗
|
1509928-00-0
|
|
Levilimab
|
乐维利单抗
|
2035008-70-7
|
|
Fenquizone
|
芬喹唑
|
20287-37-0
|
|
azidamfenicol
|
叠氮氯霉素
|
13838-08-9
|
|
GLUT inhibitor-1
|
|
2421141-40-2
|
|
GSK215
|
|
2743427-26-9
|
|
EN523
|
|
2094893-05-5
|
|
GSK 2256294A
|
|
1142090-23-0
|
|
YK-3-237
|
|
1215281-19-8
|
|
4'-C-Fluoro-uridine
|
|
1613589-24-4
|
|
Osocimab
|
奥索西单抗
|
2056878-75-0
|
|
Temelimab
|
替西木单抗
|
1393641-34-3
|
|
BAZ1A-IN-1
|
|
941521-45-5
|
|
RBN013209
|
|
2597933-17-8
|
|
Nitromazenil
|
|
84377-97-9
|
|
CJ033466
|
|
519148-48-2
|
|
SR 13800
|
|
227321-12-2
|
|
Dilpacimab
|
迪帕西单抗
|
1791420-09-1
|
|
Orilanolimab
|
奥诺利单抗
|
2066544-85-0
|
|
KSQ-4279
|
|
2446480-97-1
|